URTY:ARCA-ProShares UltraPro Russell2000 (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 50.02

Change

+2.99 (+6.36)%

Market Cap

USD 0.12B

Volume

1.19M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results that correspond to three times (3x) the daily performance of the Russell 2000? Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as three times (3x) the daily return of the index. The index is a float-adjusted, market capitalization-weighted index containing approximately 2000 of the smallest companies in the Russell 3000? Index or approximately 8% of the total market capitalization of the Russell 3000? Index, which in turn represents approximately 98% of the investable U.S. equity market. It is non-diversified.

Inception Date: 09/02/2010

Primary Benchmark: Russell 2000 TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.47%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
LFUS Littelfuse Inc 0.24 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

+2.39 (+6.39%)

USD 10.94B
QLD ProShares Ultra QQQ 0.95 %

+2.47 (+3.11%)

USD 5.97B
SSO ProShares Ultra S&P500 0.90 %

+1.39 (+1.95%)

USD 4.66B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

+24.05 (+8.54%)

USD 4.21B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

+3.30 (+2.80%)

USD 4.15B
TECL Direxion Daily Technology Bull.. 1.17 %

+2.18 (+3.24%)

USD 3.23B
UPRO ProShares UltraPro S&P500 0.92 %

+1.79 (+2.89%)

USD 2.73B
FAS Direxion Daily Financial Bull .. 1.04 %

-0.80 (-0.79%)

USD 2.45B
TNA Direxion Daily Small Cap Bull .. 1.10 %

+0.95 (+2.76%)

USD 2.23B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

+3.79 (+4.53%)

USD 1.24B

ETFs Containing URTY

RORO ATAC US Rotation ETF 0.00 % 0.00 %

+0.10 (+0.59%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.87% 40% F 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.87% 40% F 68% D+
Trailing 12 Months  
Capital Gain 38.29% 50% F 86% B+
Dividend Return 0.58% 15% F 5% F
Total Return 38.87% 47% F 85% B
Trailing 5 Years  
Capital Gain -30.56% 33% F 17% F
Dividend Return 0.67% 8% B- 2% F
Total Return -29.89% 30% F 13% F
Average Annual (5 Year Horizon)  
Capital Gain 20.76% 64% D 86% B+
Dividend Return 20.93% 63% D 84% B
Total Return 0.17% 13% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 126.35% 22% F 6% D-
Risk Adjusted Return 16.57% 43% F 42% F
Market Capitalization 0.12B 72% C 42% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.